Screening and monitoring for chronic kidney disease (CKD) could lead to earlier interventions that improve clinical outcomes. Evidence for CKD treatment benefit is strongest for angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers, and in patients with albuminuria combined with diabetes or cardiovascular disease.

This video talks about " Screening of CKD."